Results 151 to 160 of about 15,493 (167)
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia. [PDF]
Kanza EM +19 more
europepmc +1 more source
Protective Immunity Induced by Vaccination With Onchocerca volvulus Tropomyosin in Rodents
A cDNA clone of Onchocerca volvulus, designated MOv14, and encoding 136 amino-acid residues from the C-terminus of O. volvulus tropomyosin, was evaluated as a protective immunogen in two complimentary rodent models of onchocerciasis.
Mark J. Taylor +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Efficacy of Ivermectin Against Onchocerca volvulus in Ghana
Lancet, The, 2007Eddie W Cupp +2 more
exaly +4 more sources
Onchocerca volvulus and Schistosoma haematobium Infection in Southern Sierra Leone
Lancet, The, 1994Joanna Porter, J A Whitworth
exaly
Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis
PLoS Neglected Tropical Diseases, 2007James P McCarter, Sara Lustigman
exaly
Towards a Recombinant Antigen Vaccine Against Onchocerca volvulus
Trends in Parasitology, 2002Sara Lustigman, Eric R James
exaly

